LABORATORIO FARMAC.ERFO (RK7) — Financial Flexibility Index
LABORATORIO FARMAC.ERFO (RK7) has a Financial Flexibility Index of 1.21x as of December 2023. Free cash flow of €2.74 Million (operating CF €1.30 Million minus capex €1.45 Million) represents 1% of total liabilities (€2.26 Million). Check cash flow reinvestment rate of LABORATORIO FARMAC.ERFO to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
LABORATORIO FARMAC.ERFO Financial Flexibility Index (2021–2023)
Historical Financial Flexibility Index trend for LABORATORIO FARMAC.ERFO across 3 annual periods. For the full cash flow conversion analysis, see LABORATORIO FARMAC.ERFO cash flow conversion.
Annual Financial Flexibility Index for LABORATORIO FARMAC.ERFO (2021–2023)
Year-by-year free cash flow to debt coverage for LABORATORIO FARMAC.ERFO. Explore LABORATORIO FARMAC.ERFO (RK7) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.21x | €2.74 Million | €1.30 Million | €2.26 Million | ▲ +557.6% |
| 2022 | 0.18x | €1.94 Million | €761.80K | €10.53 Million | ▼ -83.9% |
| 2021 | 1.14x | €2.52 Million | €2.27 Million | €2.21 Million | — |